Insider Transactions in Q2 2024 at Macrogenics Inc (MGNX)
Insider Transaction List (Q2 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 20
2024
|
William K Heiden Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+50.0%
|
-
|
May 20
2024
|
Jay Philip Siegel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+50.0%
|
-
|
May 20
2024
|
Edward Hurwitz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+10.7%
|
-
|
May 20
2024
|
Karen Jean Ferrante Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+50.0%
|
-
|
May 20
2024
|
Meenu Chhabra Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+50.0%
|
-
|
May 20
2024
|
Margaret Liu Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+50.0%
|
-
|
May 20
2024
|
Federica F. O'Brien Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+50.0%
|
-
|
May 20
2024
|
David C Stump Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+50.0%
|
-
|
May 20
2024
|
Scott Thomas Jackson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+50.0%
|
-
|
Apr 04
2024
|
Jeffrey Stuart Peters Senior VP and General Counsel |
SELL
Open market or private sale
|
Direct |
51,395
-49.97%
|
$822,320
$16.58 P/Share
|
Apr 04
2024
|
Jeffrey Stuart Peters Senior VP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
42,500
+45.26%
|
$170,000
$4.82 P/Share
|